These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. Kaufmann M; Hortobagyi GN; Goldhirsch A; Scholl S; Makris A; Valagussa P; Blohmer JU; Eiermann W; Jackesz R; Jonat W; Lebeau A; Loibl S; Miller W; Seeber S; Semiglazov V; Smith R; Souchon R; Stearns V; Untch M; von Minckwitz G J Clin Oncol; 2006 Apr; 24(12):1940-9. PubMed ID: 16622270 [TBL] [Abstract][Full Text] [Related]
6. First-generation genomic tests for breast cancer treatment. Andre F; Delaloge S Lancet Oncol; 2010 Jan; 11(1):6-7. PubMed ID: 20005177 [No Abstract] [Full Text] [Related]
8. Treatment of advanced breast cancer with tamoxifen. Rose C; Mouridsen HT Recent Results Cancer Res; 1984; 91():230-42. PubMed ID: 6729219 [No Abstract] [Full Text] [Related]
9. Adjuvant chemoendocrine therapy in breast cancer. Bonadonna G; Valagussa P J Clin Oncol; 1986 Apr; 4(4):451-4. PubMed ID: 3514802 [No Abstract] [Full Text] [Related]
10. Systemic adjuvant therapy for node-negative breast cancer: proven or premature? Pritchard KI Ann Intern Med; 1989 Jul; 111(1):1-4. PubMed ID: 2660644 [No Abstract] [Full Text] [Related]
11. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Berns EM; Foekens JA; Vossen R; Look MP; Devilee P; Henzen-Logmans SC; van Staveren IL; van Putten WL; Inganäs M; Meijer-van Gelder ME; Cornelisse C; Claassen CJ; Portengen H; Bakker B; Klijn JG Cancer Res; 2000 Apr; 60(8):2155-62. PubMed ID: 10786679 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant systemic therapy in primary breast cancer. Mouridsen HT; Palshof T Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664 [No Abstract] [Full Text] [Related]
13. Adjuvant chemotherapy of early breast cancer. Med Lett Drugs Ther; 1990 May; 32(818):49-50. PubMed ID: 2333039 [No Abstract] [Full Text] [Related]
14. Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience. Mathew J; Agrawal A; Asgeirsson KS; Buhari SA; Jackson LR; Cheung KL; Robertson JF Breast Cancer Res Treat; 2009 Jan; 113(2):403-7. PubMed ID: 18311583 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of primary cancer of the breast in elderly women. Role of hormone therapy]. Auclerc G; Weil M; Borel C; Khayat D Presse Med; 1992 Oct; 21(34):1631-5. PubMed ID: 1470626 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant hormone treatment and chemotherapy in postmenopausal women with operable breast cancer: a retrospective analysis. Oriana S; Coradini D; Sasso GM; Di Fronzo G Anticancer Res; 1991; 11(6):2199-205. PubMed ID: 1776861 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant treatment for breast cancer: the overview. Gelber RD; Coates AS; Goldhirsch A BMJ; 1992 Apr; 304(6831):859-60. PubMed ID: 1392742 [No Abstract] [Full Text] [Related]
18. Complete remission with combination chemotherapy in metastatic breast carcinoma. Polyzos A; Buzdar AU Am J Clin Oncol; 1986 Aug; 9(4):361-3. PubMed ID: 3751975 [No Abstract] [Full Text] [Related]
19. External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer. van de Water W; Kiderlen M; Bastiaannet E; Siesling S; Westendorp RG; van de Velde CJ; Nortier JW; Seynaeve C; de Craen AJ; Liefers GJ J Natl Cancer Inst; 2014 Apr; 106(4):dju051. PubMed ID: 24647464 [TBL] [Abstract][Full Text] [Related]
20. [Adjuvant for breast cancer chemo-endocrine therapy]. Taguchi T Gan To Kagaku Ryoho; 1998 Mar; 25(4):453-67. PubMed ID: 9530350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]